首页 | 本学科首页   官方微博 | 高级检索  
检索        

18F-FDG PET/CT诊断继发性噬血细胞综合征原发病因
引用本文:李旭东,何暋易,王东宁,胡暋元,王文文,黄仁魏.18F-FDG PET/CT诊断继发性噬血细胞综合征原发病因[J].中国医学影像技术,2014,30(5):780-783.
作者姓名:李旭东  何暋易  王东宁  胡暋元  王文文  黄仁魏
作者单位:中山大学附属第三医院血液科, 广东 广州 510630;中山大学附属第三医院血液科, 广东 广州 510630;中山大学附属第三医院血液科, 广东 广州 510630;中山大学附属第三医院血液科, 广东 广州 510630;中山大学附属第三医院血液科, 广东 广州 510630;中山大学附属第三医院血液科, 广东 广州 510630
摘    要:目的 探讨18F-FDGPET/CT诊断继发性噬血细胞综合征原发病因的价值。方法 回顾性分析19例继发性噬血细胞综合征患者的18F-FDGPET/CT资料,将诊断结果与临床诊断结果进行对比;采用18F-FDGPET/CT监测3例淋巴瘤相关噬血细胞综合征疾病进展。结果 13例18F-FDGPET/CT提示为恶性淋巴瘤,表现为多发淋巴结、脾脏或骨髓高代谢灶,其中9例确诊为非霍奇金淋巴瘤,4例诊断不明;6例18F-FDGPET/CT未提示恶性肿瘤,其中2例确诊为系统性红斑狼疮、1例确诊为EB病毒感染、1例确诊为溃疡性结肠炎、1例确诊为成人斯蒂尔病,1例病因不明。3例淋巴瘤相关噬血细胞综合征患者病情改善时18F-FDGPET/CT示原高代谢灶消失,疾病复发时出现新的高代谢病灶。结论 18F-FDGPET/CT对于早期诊断继发性噬血细胞综合征的病因、尤其是鉴别疾病良恶性具有重要价值,亦可监测原发病进展情况。

关 键 词:淋巴组织细胞增多症,噬血细胞性  淋巴瘤  正电子发射型体层摄影术  氟脱氧葡萄糖F18
收稿时间:2013/12/27 0:00:00
修稿时间:2014/3/12 0:00:00

18F-FDG PET/CT in diagnosing the primary disease of secondary hemophagocytic syndrome
LI Xu-dong,HE Yi,WANG Dong-ning,HU Yuan,WANG Wen-wen and HUANG Ren-wei.18F-FDG PET/CT in diagnosing the primary disease of secondary hemophagocytic syndrome[J].Chinese Journal of Medical Imaging Technology,2014,30(5):780-783.
Authors:LI Xu-dong  HE Yi  WANG Dong-ning  HU Yuan  WANG Wen-wen and HUANG Ren-wei
Institution:Department of Hematology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;Department of Hematology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;Department of Hematology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;Department of Hematology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;Department of Hematology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;Department of Hematology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
Abstract:Objective To explore the value of 18F-FDG PET/CT in diagnosing the primary disease of secondary hemophagocytic syndrome. Methods 18F-FDG PET/CT data of 19 patients with secondary hemophagocytic syndrome were retrospectively analyzed, and the outcomes were compared with clinical results. The situation of 3 cases with lymphoma-associatied hemophagocytic syndrome was monitored with 18F-FDG PET/CT. Results Malignant lymphoma was indicted in 13 patients by 18F-FDG PET/CT, which presenting as high metabolic lesions of lymph nodes, spleen and bone marrow, among them 9 were diagnosed as non-Hodgkin's lymphoma, 4 were not finally diagnosed. Nonmalignant lesions were found in 6 patients with 18F-FDG PET/CT, among them 2 were diagnosed as systemic lupus erythematosus, 1 as Epstein-Barr virus infection, 1 as ulcerative colitis, 1 as adult onset Still's disease, and 1 was not finally diagnosed. Three patients of lymphoma-associatied hemophagocytic syndrome were monitored by 18F-FDG PET/CT, present as disappearance of high metabolic lesions when clinical symptoms improved, but appearances of new high metabolic lesions when the disease relapsed. Conclusion 18F-FDG PET/CT is of great value in diagnosing primary disease of secondary hemophagocytic syndrome, especially in differentiating benign and malignant lesions. In addition, 18F-FDG PET/CT is useful for monitoring the progresses of primary disease.
Keywords:Lymphohistiocytosis  hemophagocytic  Lymphoma  Positron-emission tomography  Fluorodeoxyglucose F18
本文献已被 CNKI 等数据库收录!
点击此处可从《中国医学影像技术》浏览原始摘要信息
点击此处可从《中国医学影像技术》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号